Manhattan Scientifics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 15, 2022 at 03:47 pm EDT
Share
Manhattan Scientifics, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 0.041 million compared to USD 0.05 million a year ago. Net loss was USD 1.62 million compared to USD 2.58 million a year ago.
For the six months, sales was USD 0.041 million compared to USD 0.05 million a year ago. Net loss was USD 2.26 million compared to USD 2.45 million a year ago.
Manhattan Scientifics, Inc. is focused on technology transfer and commercialization of these transformative technologies. The Company operates as a technology incubator. Its business model is to identify significant technologies; acquire them or the rights to them; secure the services of inventors, engineers or other staff who were instrumental in their creation; provide or contract for suitable work facilities, laboratories, and other aids where appropriate; prototype the technologies to demonstrate proof of principle feasibility; secure patent and or other intellectual property protection; secure early customers for product trials where feasible and appropriate; and commercialize through licenses, sales or cooperative efforts with other manufacturing and distribution firms. Its business model is based on licensing metals technology to metals manufacturers. Its technologies are in a development phase.
MANHATTAN SCIENTIFICS, INC. 
